Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Boffito

Showing results (61-70 of 300) with videos related to

Pageof 30
Sort By:
Sexually Transmitted Infections|January 29, 2025
Findings from trans-inclusive sexual health screening effortsBetty Swindells, Peter Endicott, Michelle O'Hora, et al.
Journal of the International AIDS Society|November 14, 2014
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
HIV Medicine|September 2, 2020
Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohortNicolò Girometti, Frances Lander, Alan McOwan, et al.
International Journal of STD & AIDS|August 11, 2020
Multimodality assessment of sleep outcomes in people living with HIV performed using validated sleep questionnairesAna Milinkovic, Suveer Singh, Bryony Simmons, et al.
AIDS (London, England)|September 16, 2015
Increasing use of 'party drugs' in people living with HIV on antiretrovirals: a concern for patient safetyMargherita Bracchi, David Stuart, Richard Castles, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2015
Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
HIV Medicine|June 7, 2026
Prior PrEP use and discontinuation in individuals newly diagnosed with HIVRohan Saini, Sarah Fidler, Marta Boffito, et al.
AIDS (London, England)|December 20, 2015
Dosing antiretroviral medication when crossing time zones: a reviewJoseph M Lewis, Alain Volny-Anne, Catriona Waitt, et al.
British Journal of Clinical Pharmacology|November 2, 2023
Anastrozole as a therapeutic option for gynecomastia in a person receiving antiretroviral therapy: Case reportElizabeth Senkoro, Maithili Varadarajan, Caterina Candela, et al.
HIV Medicine|July 14, 2021
The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIVJonathan Jin Hei Lei, Branca Pereira, Graeme Moyle, et al.
Pageof 30

Showing results (61-70 of 300) with videos related to

Sort By:
Pageof 30
Sexually Transmitted Infections|January 29, 2025
Findings from trans-inclusive sexual health screening effortsBetty Swindells, Peter Endicott, Michelle O'Hora, et al.
Journal of the International AIDS Society|November 14, 2014
Simulation of the impact of rifampicin on darunavir/ritonavir PK and dose adjustment strategies in HIV-infected patients: a population PK approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
HIV Medicine|September 2, 2020
Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohortNicolò Girometti, Frances Lander, Alan McOwan, et al.
International Journal of STD & AIDS|August 11, 2020
Multimodality assessment of sleep outcomes in people living with HIV performed using validated sleep questionnairesAna Milinkovic, Suveer Singh, Bryony Simmons, et al.
AIDS (London, England)|September 16, 2015
Increasing use of 'party drugs' in people living with HIV on antiretrovirals: a concern for patient safetyMargherita Bracchi, David Stuart, Richard Castles, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2015
Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approachLaura Dickinson, Alan Winston, Marta Boffito, et al.
HIV Medicine|June 7, 2026
Prior PrEP use and discontinuation in individuals newly diagnosed with HIVRohan Saini, Sarah Fidler, Marta Boffito, et al.
AIDS (London, England)|December 20, 2015
Dosing antiretroviral medication when crossing time zones: a reviewJoseph M Lewis, Alain Volny-Anne, Catriona Waitt, et al.
British Journal of Clinical Pharmacology|November 2, 2023
Anastrozole as a therapeutic option for gynecomastia in a person receiving antiretroviral therapy: Case reportElizabeth Senkoro, Maithili Varadarajan, Caterina Candela, et al.
HIV Medicine|July 14, 2021
The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIVJonathan Jin Hei Lei, Branca Pereira, Graeme Moyle, et al.
Pageof 30